ӳ��ý

Publications

Secure Discovery of Genetic Relatives across Large-Scale and Distributed Genomic Datasets.

Hong MM, Froelicher D, Magner R, Popic V, Berger B, Cho H. Secure Discovery of Genetic Relatives across Large-Scale and Distributed Genomic Datasets. Research in computational molecular biology : . Annual International Conference, RECOMB . : proceedings. RECOMB (Conference : 2005- ). 2024;14758:308-313. doi:10.1007/978-1-0716-3989-4_19

Secure Discovery of Genetic Relatives across Large-Scale and Distributed Genomic Datasets.

Hong MM, Froelicher D, Magner R, Popic V, Berger B, Cho H. Secure Discovery of Genetic Relatives across Large-Scale and Distributed Genomic Datasets. Research in computational molecular biology : . Annual International Conference, RECOMB . : proceedings. RECOMB (Conference : 2005- ). 2024;14758:308-313. doi:10.1007/978-1-0716-3989-4_19

Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program.

Verma A, Huffman JE, Rodriguez A, et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (New York, N.Y.). 2024;385(6706):eadj1182. doi:10.1126/science.adj1182

Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer.

Hillis AL, Martin TD, Manchester HE, et al. Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer. Cancer research. 2024. doi:10.1158/0008-5472.CAN-24-0970

Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing.

Aglago EK, Qu C, Harlid S, et al. Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing. The American journal of clinical nutrition. 2024. doi:10.1016/j.ajcnut.2024.07.012

Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer.

Hillis AL, Martin TD, Manchester HE, et al. Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer. Cancer research. 2024. doi:10.1158/0008-5472.CAN-24-0970

Early B-cell transcription factor-2 defect as a novel cause of lipodystrophy: disruption of the adipose tissue character and integrity.

Foss-Freitas MC, Gilio D, da Rocha AM, et al. Early B-cell transcription factor-2 defect as a novel cause of lipodystrophy: disruption of the adipose tissue character and integrity. medRxiv : the preprint server for health sciences. 2024. doi:10.1101/2024.06.24.24309093

"Target-and-release" nanoparticles for effective immunotherapy of metastatic ovarian cancer.

Pires IS, Covarrubias G, Gomerdinger VF, et al. "Target-and-release" nanoparticles for effective immunotherapy of metastatic ovarian cancer. bioRxiv : the preprint server for biology. 2024. doi:10.1101/2024.07.05.602135

Step Forward Cross Validation for Bioactivity Prediction: Out of Distribution Validation in Drug Discovery.

Saha US, Vendruscolo M, Carpenter AE, Singh S, Bender A, Seal S. Step Forward Cross Validation for Bioactivity Prediction: Out of Distribution Validation in Drug Discovery. bioRxiv : the preprint server for biology. 2024. doi:10.1101/2024.07.02.601740

Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.

Bouley SJ, Grassetti A V, Allaway RJ, et al. Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of cell science. 2024. doi:10.1242/jcs.262343